Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Optimized nucleic acid antibody constructs encoding anti-respiratory syncytial virus (RSV) antibodies

Optimized nucleic acid antibody constructs encoding anti-respiratory syncytial virus (RSV) antibodies

US Patent 12054537 · Granted Aug 6, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

DNA antibody constructs for use against Pseudomonas aeruginosa2025
Vaccines for recurrent respiratory papillomatosis and methods of using the same2025
DNA monoclonal antibodies targeting PD-1 for the treatment and prevention of can2025
Vaccines against Zika virus2025
Canine distemper vaccines and methods of treatment using the same2025
Vaccines against Nipah virus, and methods of using same2025
Methods and compositions for genetically modifying lymphocytes to express polype2025
DNA vaccine against crimean-congo hemorrhagic fever virus (CCHFV)2025
Cancer vaccines targeting MUC16 and uses thereof2025
Vaccines having an antigen and interleukin-21 as an adjuvant2025
Marburgvirus consensus antigens, nucleic acid constructs and vaccines made there2025
Methods and compositions for transducing lymphocytes and regulating the activity2025